Control, non-CVH (n=251) | CVH | |||
---|---|---|---|---|
HBV (n=83) | HCV (n=41) | HBV+HCV (n=4) | ||
Age, years | 59.3±17.3 | 50.0±15.1a | 59.9±14.9 | 54.3±9.5 |
Sex, female | 155 (61.8) | 61 (73.5) | 27 (65.9) | 4 (100) |
Use of PZA | 235 (93.6) | 68 (81.9) a | 36 (87.8) | 3 (75.0) |
DM | 49 (19.5) | 18 (21.7) | 17 (41.5) a | 2 (50.0) |
HCC | 1 (0.4) | 7 (8.4) a | 2 (4.9) | 0 (0) |
Other malignancy | 42 (16.7) | 8 (9.8) | 2 (4.9) | 0 (0) |
Alcohol ingestionb | 42 (16.7) | 9 (10.8) | 7 (17.1) | 1 (25) |
Extrapulomary TB | 72 (28.7) | 24 (28.9) | 8 (19.5) | 0 (0) |
Past TB history | 30 (12.0) | 19 (22.9) a | 7 (17.1) | 2 (50) |
BMI >25kg/m2 | 37 (16.5) | 8 (10.3) | 6 (15.4) | 0 (0) |
Liver cirrhosis | 3 (1.2) | 21 (25.3) a | 4 (9.8) a | 2 (50) a |
CKD | 13 (5.2) | 3 (3.6) | 2 (4.9) | 0 (0) |
Baseline LFT abnormalityc | 27 (10.8) | 21 (25.3) a | 15 (36.6) a | 2 (50) |